Metastatic behavior of prostatic tumor as influenced by the hematopoietic and hematogenous factors

Tumor Biology

Volumn 18, Issue 1, 1997, Pages 1-5

  Bhatti, Rashid A ^a   Gadarowski, John J ^a   Ray, Paul S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Growth factors; Metastasis; Prostate cancer

Indexed keywords

GROWTH FACTOR; TRANSFERRIN; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RAT; THROMBOCYTE;

EID: 0031021535     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000218009     Document Type: Article

References (10)

1. Boring CC, Squires TS, Tong T, Montgomery S: Cancer Statistics, Cancer 1994:44:7.
2. Kircheimer J, Roller A, Binder B: Isolation and characterization of plasminogen activators from hyperplastic and malignant prostatic tissue, Biochim Biophys Acta 1984; 797:256-265.
3. Honn VK, Tang DG, Crissman JD: Platelets and cancer metastasis, A casual relationship? Cancer Metastasis Rev 1992;11:325-345.
4. Rossi MC, Zetter RB: Selective stimulation of prostatic carcinoma cell proliferation by transferrin, Proc Natl Acad Sci USA 1992;89: 6197-6201.
5. Ncwhousc P, Clark C: The quantitation of platelet aggregation in platelet function: in Douglas T (ed): Lab Evaluation and Clinical Application, Chicago, Am Soc Clin Pathol, 1978, p 10.
6. Bhatti R, Ablin R, Guinan P: Evaluation of leukocyte adherence inhibition in prostatic cancer, in Thomson DMT (ed): An Assessment of the Immune Status by Leukocyte Inhibition Test, New York, Academic Press, 1982, pp 185-206.
7. Markus G: The relevance of plasminogen activators to neoplastic growth, Enzyme 1988;40:158-172.
8. Bhatti R, Gadarowski J, Ray P: The role of blood platelets in the hematogenous dissemination of prostatic cancer, J Cancer Res Clin Oncol 1990; 116:553.
9. Ray P, Bhatti R, Gadarowski J, Bashir A: Modulatory effects of tumor cells on the hematogenous factors in prostatic cancer; in Biuliani L, Pup-po P (eds): Urology, Bologna, Mon-duzzi, 1992, pp 539-543.
10. Bhatti R, Ray P, Gadarowski J, Hkay A: The role of urokinase plasminogen activators, the hematogenous factors and the effect of transferrin in the metastatic cascade of prostatic cancer; in Rao R, Deo M, Sanghvi L, (eds): Proceedings 16th International Cancer Congress, Bologna, Monduzzi, 1994, vol 3, pp 2205-2209.